To demonstrate safety and effectiveness of lumen-apposing metal stents for resolution of walled off pancreatic necrosis (WONs) in patients with WONs with solid component \>30%.
This study is a prospective, single arm, multi-center trial. Treatment of up to 40 patients will take place at up to 6 clinical centers. Patients who meet all eligibility criteria will receive the AXIOS stent for up to 60 days stent indwell and 6 months follow-up after stent removal.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
40
Patient will receive either transgastric or transduodenal endoscopic drainage for walled-off necrosis that are adherent to the gastric or bowel wall.
University of Colorado, Denver
Aurora, Colorado, United States
Emory University Healthcare
Atlanta, Georgia, United States
Indiana University Health
Indianapolis, Indiana, United States
Brigham & Women's Hospital
Boston, Massachusetts, United States
Number of Participants With Resolution of WON With Endoscopic Drainage
Resolution of WON with endoscopic drainage defined as radiographic decrease of WON size to ≤ 3cm evaluated by CT scan or MRI
Time frame: Up to 60 Days
AXIOS Stent Related or WON Drainage Procedure Related Serious Adverse Events
AXIOS stent related or WON drainage procedure related serious adverse events
Time frame: Through study completion, average of 8 months
Symptom Reduction
Reduction of WON-related clinical symptoms. Note: WON-related symptoms as defined in Inclusion Criteria #4
Time frame: Through study completion, average of 8 months
Technical Success
Technical AXIOS stent placement success, defined as placement in desired location using endoscopic/EUS techniques per standard of practice. Technical AXIOS stent removal success, defined as ability to remove the AXIOS stent using an endoscopic snare or forceps or graspers without AXIOS stent removal related serious adverse events.
Time frame: Intraoperative (Stent placement)
Drainage Procedural Time
Time elapsed between initial puncture of the WON with electrocautery to endoscope retrieval.
Time frame: Intraoperative (Stent placement)
Resolution of WON: Radiographic Resolution Evaluated by MRI or CT
Resolution of WON with or without necrosectomy by 6 months post AXIOS stent removal.
Time frame: Through study completion, average of 8 months
Time to WON Resolution
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Mayo Clinic
Rochester, Minnesota, United States
Time to WON resolution using same definition as for primary endpoint, namely: * Resolution of WON with endoscopic drainage defined as radiographic decrease of WON size to ≤ 3cm evaluated by CT scan or MRI.
Time frame: Up to 60 Days
WON Recurrence
Recurrence of WON after initial resolution and up to 6 months post AXIOS stent removal.
Time frame: Through study completion, average of 8 months
Stent Lumen Patency
Stent lumen patency, evaluated via imaging or direct visual inspection with endoscope, and defined as one or both of the following: * Drainage through AXIOS stent visualized from the stomach or bowel, and/or * Visual confirmation of AXIOS stent lumen patency
Time frame: Intraoperative (Stent placement through stent removal)
Fluoroscopy
Fluoroscopy (time) per endoscopic procedure.
Time frame: Intraoperative (Stent placement through stent removal)
Incidence of New Organ Failure
Number of participants with new organ failure from drainage procedure to WON resolution.
Time frame: Up to 60 days
Change in SF-12 Score
\*Change\* in Quality of Life score (SF-12 questionnaire) from \*baseline to stent removal\*. The SF-12 is a health-related quality-of-life questionnaire consisting of twelve questions that measure eight health domains to assess physical and mental health. Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning
Time frame: Difference from baseline to stent removal (up to 60 days) visit